TY  - JOUR 
AU  - Mesquida, Aina
AU  - Vicente, Teresa
AU  - Reigadas, Elena
AU  - Palomo, María
AU  - Sánchez-Carrillo, Carlos
AU  - Muñoz, Patricia
AU  - Guinea, Jesús
AU  - Escribano, Pilar
PY  - 2021
SN  - 1198-743X
UR  - http://hdl.handle.net/20.500.12020/1301
AB  - Objectives: Emergence of azole resistance may contribute to recurrences of vulvovaginal candidiasis.
Thus, new drugs are needed to improve the therapeutic options. We studied the in vitro activity of
ibrexafungerp and comparators against Candida...
LA  - en
PB  - Elsevier
TI  - In vitro activity of ibrexafungerp and comparators against Candida albicans genotypes from vaginal samples and blood cultures
DO  - 10.1016/j.cmi.2021.02.006
T2  - Clinical Microbiology and Infection
M2  - 915.e5
KW  - Antifungal susceptibility
KW  - Candida albicans
KW  - EUCAST
KW  - Genotyping
KW  - Ibrexafungerp
KW  - Microsatellites
KW  - Vulvovaginal candidiasis
VL  - 27
ER  -